Abstract
Nonviral gene delivery methods with naked plasmids and various plasmid carrier complexes have been used for intravascular, intramuscular and periadventitial gene delivery to cardiovascular system. Efficacy, homogenity and quality of the nonviral gene delivery complexes can be significantly affected by the way they are produced. This chapter presents basic methods to produce nonviral gene delivery complexes and describes common models to test their properties in cardiovascular applications in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ylä-Herttuala, S. and Martin, J. F (2000) Cardiovascular gene therapy. Lancet 355,213–222.
Boussif, O., Lezoualch, F., Zanta, M. F., et al. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297–7301.
Zabner, J., Fasbender, A. J., Moninger, K., Poellinger, K., and Welsh, M. J. (1995) Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270,18997–19007.
Ruponen, M., Rönkkö S., Honkakoski, P., Pelkonen, J., Tammi, M., and Urtti, A. (2001) Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J. Biol. Chem. 276, 33,875–33,880.
Hiltunen, M., Turunen, M., and Ylä-Herttuala, S. (2001) Gene therapy methods in cardiovascular diseases. Meth. Enzymol. 346, 311–320.
Hiltunen, M. O., Turunen, M. P., Turunen, A-M., et al. (2000) Biodistribution of adenoviral vector to nontarget tissues after in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods. FASEB J. 14, 2230–2236.
Laitinen, M., Mäkinen, K., Manninen, H., et al. (1998) Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum. Gene Ther. 9,1481–1486.
Mäkinen, K., Manninen, H., Hedman, M., et al. (2002) Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery. A randomized, placebo-controlled, double-blinded Phase II study. Mol. Ther. 6, 127–133.
Turunen, M.P., Hiltunen, M.O., Ruponen, M., et al. (1999) Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Ther. 6,6–11.
Aihara, H. and Miyazaki, J. (1998) Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867–870.
Ylä-Herttuala, S. and Alitalo, K. (2003) Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9,694–701.
Koivunen, E., Arap, W., Valtanen, H., et al. (1999) Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol. 17, 768–774.
Budker, V., Zhang, G., Danko, I., Williams, P., and Wolff, J. (1998) The efficient expression of intravascularly delivered DNA in rat muscle. Gene Ther. 5,272–276.
Vicat, J. M., Boisseau, S., Jourdes, P., et al. (2000) Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. Hum. Gene Ther. 11,909–916.
Lawrie, A., Brisken, A. F., Francis, S. E., et al. (1999) Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 99,2617–2620.
Lin, W. C., Pretlow, T. P., Pretlow 2nd, T. G., and Culp, L. A. (1990) Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. Cancer Res. 50,2808–2817.
Weiss, D. J., Liggitt, D., and Clark, J. G. (1997) In situ histochemical detection of beta-galactosidase activity in lung assessment of X-Gal reagent in distinguishing lacZ gene expression and endogenous beta-galactosidase activity. Hum. Gene Ther. 8, 1545–1554.
Sambrook, J. and Russell, D. W. (2001) Molecular Cloning: A Laboratory Manual, 3rd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 17.33–17.51.
Seliger, H. H. and McElroy, W. D. (1960) Spectral emission and quantum yield of firefly bioluminescence. Arch. Biochem. Biophys. 88, 136–141.
de Wet, J. R., Wood, K. V., Helinski, D. R., and DeLuca, M. (1985) Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc. Natl. Acad. Sci. USA 82, 7870–7873.
Berger, J., Hauber, J., Hauber, R., Geiger, R., and Cullen, B. R. (1988) Secreted placental alkaline phosphatase: a powerful new qualitative indicator of gene expression in eukaryotic cells. Gene 66, 1–10.
Chalfie, M., Tu, Y., Euskrirchen, G., Ward, W. W., and Prasher, D. C. (1994) Green fluorescent protein as a marker for gene expression. Science 263,802–805.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Ruponen, M., Hyvönen, Z., Urtti, A., Ylä-Herttuala, S. (2005). Nonviral Gene Delivery Methods in Cardiovascular Diseases. In: Fennell, J.P., Baker, A.H. (eds) Hypertension. Methods In Molecular Medicine™, vol 108. Humana Press. https://doi.org/10.1385/1-59259-850-1:315
Download citation
DOI: https://doi.org/10.1385/1-59259-850-1:315
Publisher Name: Humana Press
Print ISBN: 978-1-58829-323-7
Online ISBN: 978-1-59259-850-2
eBook Packages: Springer Protocols